Literature DB >> 23895021

Mitochondria and arrhythmias.

Cody Rutledge, Samuel Dudley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23895021      PMCID： PMC4211874          DOI： 10.1586/14779072.2013.811969

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN： 1477-9072


× No keyword cloud information.
  20 in total

1.  Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?

Authors:  Biswadeep Das; Chayna Sarkar
Journal:  Life Sci       Date:  2005-07-29       Impact factor: 5.037

2.  Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells.

Authors:  B O'Rourke; B M Ramza; E Marban
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

Review 3.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

Review 4.  Myocardial K(ATP) channels in preconditioning.

Authors:  B O'Rourke
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

5.  Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a.

Authors:  G Alex Papadatos; Polly M R Wallerstein; Catherine E G Head; Rosemary Ratcliff; Peter A Brady; Klaus Benndorf; Richard C Saumarez; Ann E O Trezise; Christopher L-H Huang; Jamie I Vandenberg; William H Colledge; Andrew A Grace
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 6.  Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia.

Authors:  G E Billman
Journal:  Cardiovasc Res       Date:  1994-06       Impact factor: 10.787

7.  Effects of sulfonylurea hypoglycemic agents and adenosine triphosphate dependent potassium channel antagonists on ventricular arrhythmias in patients with decompensated heart failure.

Authors:  Doron Aronson; Murray A Mittleman; Andrew J Burger
Journal:  Pacing Clin Electrophysiol       Date:  2003-05       Impact factor: 1.976

8.  Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death.

Authors:  Ali A Sovari; Shahriar Iravanian; Elena Dolmatova; Zhe Jiao; Hong Liu; Shadi Zandieh; Vibhash Kumar; Kun Wang; Kenneth E Bernstein; Marcelo G Bonini; Heather S Duffy; Samuel C Dudley
Journal:  J Am Coll Cardiol       Date:  2011-11-22       Impact factor: 24.094

Review 9.  Metabolic stress, reactive oxygen species, and arrhythmia.

Authors:  Euy-Myoung Jeong; Man Liu; Megan Sturdy; Ge Gao; Susan T Varghese; Ali A Sovari; Samuel C Dudley
Journal:  J Mol Cell Cardiol       Date:  2011-09-25       Impact factor: 5.000

10.  Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death.

Authors:  Ali A Sovari; Cody A Rutledge; Euy-Myoung Jeong; Elena Dolmatova; Divya Arasu; Hong Liu; Nooshin Vahdani; Lianzhi Gu; Shadi Zandieh; Lei Xiao; Marcelo G Bonini; Heather S Duffy; Samuel C Dudley
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-04-04
View more
  9 in total

1.  Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.

Authors:  Larisa Emelyanova; Zain Ashary; Milanka Cosic; Ulugbek Negmadjanov; Gracious Ross; Farhan Rizvi; Susan Olet; David Kress; Jasbir Sra; A Jamil Tajik; Ekhson L Holmuhamedov; Yang Shi; Arshad Jahangir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 2.  Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients.

Authors:  Karan R Chadda; Ibrahim T Fazmin; Shiraz Ahmad; Haseeb Valli; Charlotte E Edling; Christopher L-H Huang; Kamalan Jeevaratnam
Journal:  Sleep       Date:  2018-09-01       Impact factor: 5.849

Review 3.  Quantification of Myocardial Mitochondrial Membrane Potential Using PET.

Authors:  Matthieu Pelletier-Galarneau; Felicitas J Detmer; Yoann Petibon; Marc Normandin; Chao Ma; Nathaniel M Alpert; Georges El Fakhri
Journal:  Curr Cardiol Rep       Date:  2021-05-10       Impact factor: 2.931

4.  In-vivo Imaging of Mitochondrial Depolarization of Myocardium With Positron Emission Tomography and a Proton Gradient Uncoupler.

Authors:  Nathaniel M Alpert; Matthieu Pelletier-Galarneau; Sally Ji Who Kim; Yoann Petibon; Tao Sun; Karla M Ramos-Torres; Marc D Normandin; Georges El Fakhri
Journal:  Front Physiol       Date:  2020-05-15       Impact factor: 4.566

Review 5.  Mitochondrial and Sarcoplasmic Reticulum Interconnection in Cardiac Arrhythmia.

Authors:  Felipe Salazar-Ramírez; Roberto Ramos-Mondragón; Gerardo García-Rivas
Journal:  Front Cell Dev Biol       Date:  2021-01-28

6.  Mitochondrial-Respiration-Improving Effects of Three Different Gardeniae Fructus Preparations and Their Components.

Authors:  Yun Wang; Puling Li; Xue Zhang; Lingyun Li; Mengjiao Liu; Xiaoqing Li; Yejia Dai; Cun Zhang; Shaojing Li
Journal:  ACS Omega       Date:  2021-12-07

Review 7.  Desmin variants: Trigger for cardiac arrhythmias?

Authors:  Wei Su; Stan W van Wijk; Bianca J J M Brundel
Journal:  Front Cell Dev Biol       Date:  2022-09-09

8.  In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study.

Authors:  Matthieu Pelletier-Galarneau; Yoann Petibon; Chao Ma; Paul Han; Sally Ji Who Kim; Felicitas J Detmer; Daniel Yokell; Nicolas Guehl; Marc Normandin; Georges El Fakhri; Nathaniel M Alpert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-27       Impact factor: 9.236

9.  Quantitative in vivo mapping of myocardial mitochondrial membrane potential.

Authors:  Nathaniel M Alpert; Nicolas Guehl; Leon Ptaszek; Matthieu Pelletier-Galarneau; Jeremy Ruskin; Moussa C Mansour; Dustin Wooten; Chao Ma; Kazue Takahashi; Yun Zhou; Timothy M Shoup; Marc D Normandin; Georges El Fakhri
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.